Table 1.

Correlations between the expression of SPHK1, HAS2, and clinicopathological characteristics in pancreatic cancer.

Characteristics		Total	HAS2		P	SPHK1		P
			High	Low		High	Low
Age	≥49	163	80	83	0.75	81	82	0.28
	<49	14	9	5		8	6
Gender	Male	97	44	53	0.17	49	48	1.00
	Female	80	45	35		40	40
Stage	I	21	10	11	0.907	6	15	0.003
	II	146	74	72		78	68
	III+IV	7	4	3		3	4
	NA	3	-	-		-	-
T stage	T1+T2	31	14	17	0.48	10	21	0.03
	T3+T4	144	75	69		78	66
	NA	2
N stage	N0	49	21	28	0.98	23	26	0.50
	N1	123	63	60		65	58
	NA	5	-	-		-	-
Tumor location	Head of pancreas	129	60	69	0.10	71	58	0.007
	Body of pancreas	15	10	5		6	9
	Tail of pancreas	14	5	9		3	11
	Other	19	13	6		8	11

^∗ P < 0.05.